Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.01484 | 42 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.01837 | 44 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.05238 | 45 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.07416 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.41419 | 57 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.08755 | 43 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.04967 | 43 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.02816 | 44 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.02361 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.06429 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.03725 | 45 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.01688 | 45 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.01167 | 43 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.02922 | 44 |